- Home
- EXEL vs MASI Comparison
EXEL vs MASI Comparison
Compare EXEL & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | MASI |
|---|---|---|
| Founded | 1994 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.2B |
| IPO Year | 2000 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EXEL | MASI |
|---|---|---|
| Price | $44.90 | $178.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 5 |
| Target Price | $46.50 | ★ $184.00 |
| AVG Volume (30 Days) | ★ 2.1M | 749.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | 51.05 |
| EPS | ★ 2.78 | N/A |
| Revenue | $452,477,000.00 | ★ $1,239,153,000.00 |
| Revenue This Year | $13.61 | $8.59 |
| Revenue Next Year | $13.13 | $7.66 |
| P/E Ratio | $16.56 | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $33.76 | $125.94 |
| 52 Week High | $48.74 | $179.00 |
Technical Indicators
Market Signals| Indicator | EXEL | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 69.38 |
| Support Level | $40.98 | $176.68 |
| Resistance Level | $46.46 | $178.93 |
| Average True Range (ATR) | 1.41 | 0.29 |
| MACD | 0.09 | -0.49 |
| Stochastic Oscillator | 34.64 | 61.90 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MASI Masimo Corporation
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.